Advertisement Rigel offers four million shares of common stock - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Rigel offers four million shares of common stock

Rigel Pharmaceuticals has announced that it will initiate an offering of four million shares of common stock pursuant to an automatically effective shelf registration statement on file with the Securities and Exchange Commission.

It is currently anticipated that the underwriters will be granted an over-allotment option for an additional 600,000 shares. Credit Suisse Securities (USA) will be acting as the sole book-runner for the offering, with Thomas Weisel Partners, Jefferies & Company, and Oppenheimer & Co. acting as co-managers.